BROADCASTS.com

The buzz: Drug supply risks. Today, more often than is acceptable, a required antibiotic or chronic disease drug cannot be delivered on time. What will happen tomorrow when personalized medicine tailored for one or a small patient group must be secured? The experts speak. Dr. Josef Packowski, CAMELOT Consulting Group: \u201cDetective Del Spooner: \u2018You are just a machine. An imitation of life. Can a robot write a symphony?\u2019 Sonny: \u2018Can you?\u2019\u201d (I, Robot). Julian Amey, WMG: \u201cGentlemen, we can rebuild him. We have the technology. We have the capability to make the world's first bionic man. Steve Austin will be that man\u2026Better...stronger...faster\u201d (The Six Million Dollar Man). Jack Schmidt, SAP: \u201c\u2026one of my mantras\u2013focus and simplicity. Simple can be harder than complex: You have to work hard to get your thinking clean to make it simple. But it\u2019s worth it in the end because once you get there, you can move mountains\u201d (Steve jobs). Join us for Future of Medicine: Will Supply Chains Be Ready?